Semler Scientific, Inc. (OTCMKTS:SMLR) Short Interest Up 350.0% in December

Semler Scientific, Inc. (OTCMKTS:SMLR) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 2,700 shares, a growth of 350.0% from the December 15th total of 600 shares. Based on an average daily volume of 41,500 shares, the short-interest ratio is currently 0.1 days.

OTCMKTS SMLR traded down $1.75 on Wednesday, reaching $84.00. 65,089 shares of the company’s stock traded hands, compared to its average volume of 23,561. Semler Scientific has a 12 month low of $30.00 and a 12 month high of $95.00. The stock has a 50-day simple moving average of $84.72 and a 200 day simple moving average of $62.31. The stock has a market cap of $562.80 million, a PE ratio of 48.45, a P/E/G ratio of 2.40 and a beta of 0.97.

Semler Scientific (OTCMKTS:SMLR) last released its earnings results on Thursday, November 5th. The medical equipment provider reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.44. The company had revenue of $10.73 million during the quarter, compared to analyst estimates of $8.62 million. Semler Scientific had a return on equity of 64.58% and a net margin of 42.42%. On average, equities analysts predict that Semler Scientific will post 0.94 EPS for the current fiscal year.

Separately, Lake Street Capital upped their target price on Semler Scientific from $75.00 to $100.00 and gave the company a “buy” rating in a report on Friday, November 6th.

About Semler Scientific

Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

See Also: Forex

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with's FREE daily email newsletter.